
Why women’s health needs a system redesign to close the diagnostics gap
We must redesign women's health systems around early detection and integrated care, and recognize diagnostics as being foundational to effective care.
Dr Stephanie Allen is a globally recognised healthcare leader with more than 25 years' experience advising healthcare and life sciences businesses worldwide on the future of health.
She is currently CEO of Jumpstart Fertility - a Boston-headquartered Biotech developing platforms to enhance Women's fertility. She is also the Head of Global Partnerships at Eucalyptus Health where she is actively establishing commercial partnerships with insurers, providers and retailers and serves as a Senior Advisor to Kearney, contributing to the [w]Health platform.
Formerly, Stephanie was responsible for driving the world's largest healthcare advisory business as Deloitte's Global Healthcare Leader. She is widely known for her leadership in emerging health policy and has contributed to global initiatives with the World Economic Forum, UN Women and the George Institute.
Stephanie serves as a Non-Executive Director for North Sydney Local Health District, overseeing commercialisation strategy and serving as a member of the Risk and Audit Committee.
We must redesign women's health systems around early detection and integrated care, and recognize diagnostics as being foundational to effective care.
精神疾病可谓是疫情之后席卷全球的“第二波流行病”。此刻,全球精神卫生界都亟需寻求创新的解决方案。各种各样的解决方案带来了一个新的问题:如何确保人们所使用的种种颠覆性技术是通过了临床验证、符合道德且切实有效的?世界经济论坛与德勤合作制定了一套用于审查这些解决方案的标准,叫做“数字心理健康全球治理工具包”。
WEF has partnered with Deloitte to create standards to vet digital mental health solutions called the Global Governance Toolkit for Digital Mental Health.

